Literature DB >> 17971296

Chemically modified symmetric and asymmetric duplex RNAs: an enhanced stability to nuclease degradation and gene silencing effect.

Takanori Kubo1, Zhivko Zhelev, Hideki Ohba, Rumiana Bakalova.   

Abstract

The present study accents on the relationship between dicing, nuclease stability, and RNAi activity of various types of chemically modified symmetric and asymmetric dsRNAs, covalently bound with amino-groups or cholesterol at one or both terminals. All modified dsRNAs were subjected to cleavage by recombinant Dicer enzyme. They possessed a high resistance to nuclease degradation in cell cultured medium and an excellent RNAi activity in viable cells. The best stability and RNAi activity was detected for 5'-sense amino-modified RNAs. These modifications manifested also a high long-term gene silencing effect within seven days post-transfection, while the RNAi activity of the native 21nt siRNA expired within two days. The conjugation of dsRNA with cholesterol at 5'-sense end resulted in easy intracellular delivery without transfection reagents. After a direct transfection in cells, the cholesterol-conjugated 27nt dsRNA possessed a higher RNAi activity than cholesterol-conjugated 21nt siRNA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17971296     DOI: 10.1016/j.bbrc.2007.10.116

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Duplex end breathing determines serum stability and intracellular potency of siRNA-Au NPs.

Authors:  Pinal C Patel; Liangliang Hao; Weng Si Au Yeung; Chad A Mirkin
Journal:  Mol Pharm       Date:  2011-06-28       Impact factor: 4.939

Review 2.  RNA interference trigger variants: getting the most out of RNA for RNA interference-based therapeutics.

Authors:  Nicholas M Snead; John J Rossi
Journal:  Nucleic Acid Ther       Date:  2012-06       Impact factor: 5.486

3.  siRNA Vehicles for High Endosomal Escapability.

Authors:  Hiroyuki Koide; Sei Yonezawa; Tomohiro Asai
Journal:  Methods Mol Biol       Date:  2021

Review 4.  Progress toward in vivo use of siRNAs-II.

Authors:  Garrett R Rettig; Mark A Behlke
Journal:  Mol Ther       Date:  2011-12-20       Impact factor: 11.454

Review 5.  Gold nanoparticles for biology and medicine.

Authors:  David A Giljohann; Dwight S Seferos; Weston L Daniel; Matthew D Massich; Pinal C Patel; Chad A Mirkin
Journal:  Angew Chem Int Ed Engl       Date:  2010-04-26       Impact factor: 15.336

6.  Modified dsRNAs that are not processed by Dicer maintain potency and are incorporated into the RISC.

Authors:  William Salomon; Karen Bulock; Jennifer Lapierre; Pamela Pavco; Tod Woolf; Joanne Kamens
Journal:  Nucleic Acids Res       Date:  2010-02-18       Impact factor: 16.971

Review 7.  Nanotechnology, nanotoxicology, and neuroscience.

Authors:  Won Hyuk Suh; Kenneth S Suslick; Galen D Stucky; Yoo-Hun Suh
Journal:  Prog Neurobiol       Date:  2008-09-24       Impact factor: 11.685

8.  Molecular basis for improved gene silencing by Dicer substrate interfering RNA compared with other siRNA variants.

Authors:  Nicholas M Snead; Xiwei Wu; Arthur Li; Qi Cui; Kumi Sakurai; John C Burnett; John J Rossi
Journal:  Nucleic Acids Res       Date:  2013-04-24       Impact factor: 16.971

9.  RNA interference approaches for treatment of HIV-1 infection.

Authors:  Maggie L Bobbin; John C Burnett; John J Rossi
Journal:  Genome Med       Date:  2015-05-28       Impact factor: 11.117

Review 10.  On the use of short-interfering RNA to study alcohol-related genes.

Authors:  Christopher A Adams; W Michael Zawada
Journal:  Alcohol Res Health       Date:  2008
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.